TARO Stock Price, Chart, Stats & News

Taro Pharmaceutical Industries Ltd.
Save
1.62B
Market cap
30.05x
Current P/E
–
Forward P/E
TARO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 48.47% |
Operating margin | 3.42% |
Pretax margin | 13.14% |
Net margin | 8.56% |
Effective tax rate | 34.84% |
ROA | 2.49% |
ROE | 3.06% |
D/E | – |
Interest coverage ratio | – |
TARO valuation
P/E | 30.05x |
P/S | 2.57x |
P/B | 0.90x |
P/CF | 12.20x |
P/FCF | 20.66x |
P/OCF | 12.20x |
PEG | 0.30x |
EV multiple | 51.51x |
About
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products.
Similar securities
Based on sector and market capitalization
Report issue











